查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1808389

吸入麻醉剂市场按产品类型、年龄层、应用、最终用户和分销管道划分－2025-2030 年全球预测

Inhalation Anesthetics Market by Product Type, Age Group, Application, End User, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2024 年吸入麻醉剂市场价值为 16.2 亿美元，预计 2025 年将成长至 17.5 亿美元，复合年增长率为 8.41%，到 2030 年将达到 26.3 亿美元。

主要市场统计数据
基准年2024年 16.2亿美元
预计2025年 17.5亿美元
预测年份 2030 26.3亿美元
复合年增长率（%） 8.41%

探索吸入麻醉剂的创新作用和进步，重新定义现代外科和重症加护。

近两个世纪以来，吸入麻醉剂一直是现代麻醉实践的基石，从最初的乙醚和氯仿配方发展到如今旨在快速起效、精准控制和极低副作用的先进药剂。本介绍介绍了改变外科治疗的技术突破，使临床医生能够在各种外科环境中提供一致、安全的麻醉。挥发性麻醉剂和麻醉剂的出现，麻醉剂镇静深度和恢復方案能够根据患者的个别需求进行客製化。

评估技术管理和法律规范的关键转变，推动吸入麻醉高效、安全和精准的新时代

由于技术创新、安全标准加强以及环境永续性要求的提高，吸入麻醉剂领域正在迅速发展。近年来，闭路麻醉输送系统已被整合，以最大限度地减少废气排放并优化药物利用率。这些系统与先进的监测工具结合，可以更密切地控制麻醉剂浓度、通气参数和病患血流动力学，从而降低术中不稳定的风险。

分析 2025 年美国关税对供应链、营运成本以及影响吸入麻醉供应商的策略采购决策的综合影响

2025年美国新关税的实施将给吸入麻醉剂供应链带来多方面的挑战，影响原料采购、製造成本和分销经济效益。依赖进口前驱化学品的供应商正面临投入成本上升的压力，促使他们重新审视采购路线和合约条款。因此，製造商正在重新定位其生产基地，并考虑近岸外包或国内扩张，以减轻关税负担。

解读关键细分动态，了解产品类型、年龄层、应用、最终用户和分销管道如何塑造多样化的吸入麻醉剂市场

要了解吸入麻醉剂满足临床需求的多种途径，需要彻底研究市场区隔。麻醉剂剂和挥发性麻醉剂的差异凸显了其在配方和给药方式上的根本差异。后者包括地DESFLURANE、恩氟烷、氟烷、Isoflurane和SEVOFLURANE等药物，每种药物都具有独特的药物动力学特征和恢復特性。这些细微的产品层面差异会影响临床医师的偏好和购买决策，尤其是在平衡起效速度和代谢负担时。

绘製区域成长轨迹，了解美洲、欧洲、中东和非洲以及亚太地区如何影响吸入麻醉的需求和战略重点

区域动态在塑造吸入麻醉剂的市场机会和挑战方面发挥关键作用。在美洲，先进的医疗基础设施和高手术量推动了对优质麻醉剂和耦合输送系统的持续需求。美国和加拿大的监管机构强调严格的安全和环境标准，创造了一个高度重视低排放雾化器和药物製剂创新的环境。

确定主要企业的策略性措施和竞争格局，突显影响吸入麻醉剂产业格局的技术创新和市场竞争

主要企业的吸入麻醉剂公司正在采用各种策略来保持竞争优势并抓住新机会。许多公司正在加快对绿色化学和闭合迴路输送技术的投资，以满足不断变化的环境法规和最终用户的需求。与医疗设备和软体开发商的策略联盟正在打造整合麻醉平台，将药物传递与进阶分析相结合，从而增强病患监测。

提供可行的策略建议，帮助产业领导者克服吸入麻醉剂领域的监管复杂性、创新需求和市场进入挑战

行业领导者可以透过采取多种可行的策略来巩固其市场地位。首先，面对日益严格的环境法规，优先研发低排放麻醉剂和闭路输送系统可以使其产品脱颖而出。在配方科学和设备整合方面的投资有助于满足临床医生的偏好和永续性的要求。

阐明可靠数据收集、分析检验和对吸入麻醉剂市场动态研究调查方法的洞察背后的严谨调查方法方法

支撑本分析的研究采用了一种全面、多层次的方法，旨在确保准确性、可靠性和效度。主要研究包括对关键意见领袖的深入访谈，包括麻醉师、采购经理、监管专家和设备工程师。这些第一手的见解有助于深入了解临床偏好、营运挑战以及技术应用的障碍。

综合考虑关键趋势、技术进步、监管影响和竞争策略的结论决定了吸入麻醉剂产业的未来发展轨迹

吸入麻醉剂产业正处于临床创新、法规演变和永续性要求的十字路口。药物配方和给药系统的技术进步正在提升安全性、营运效率和环境绩效。同时，新的关税制度和排放指南等监管变化正在重塑供应链策略和成本结构。

目录

第一章：前言

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章市场动态

  • 增加低影响麻醉剂的采用，以减少手术室的碳排放
  • 加强对排放更低的下一代地DESFLURANE替代品的监管核准
  • 门诊手术中心对超速效吸入麻醉剂的需求不断增加
  • 亚太地区新兴医疗体系吸入麻醉剂市场不断扩大
  • 回应全球永续性的需求，转向环境友善的麻醉通讯协定
  • 已开发市场非专利吸入麻醉剂替代带来的竞争性定价压力

第六章 市场洞察

  • 波特五力分析
  • PESTEL分析

第七章 2025年美国关税的累积影响

8. 吸入麻醉剂市场（依产品类型）

  • 气体麻醉剂
  • 挥发性麻醉剂
    • DESFLURANE
    • 恩氟烷
    • 氟烷
    • Isoflurane
    • SEVOFLURANE

9. 吸入麻醉剂市场（依年龄层）

  • 成人
  • 老年人
  • 孩子们

第 10 章吸入麻醉剂市场（按应用）

  • 麻醉诱导
  • 麻醉维持

第 11 章吸入麻醉剂市场（依最终使用者）

  • 门诊手术中心（ASC）
  • 医院
  • 加护病房
  • 军医院/野战医院
  • 专科诊所
  • 兽医诊所

第 12 章吸入麻醉剂市场（依分销管道）

  • 离线
  • 在线的

13.美洲吸入麻醉剂市场

  • 美国
  • 加拿大
  • 墨西哥
  • 巴西
  • 阿根廷

14. 欧洲、中东和非洲吸入麻醉剂市场

  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 阿拉伯聯合大公国
  • 沙乌地阿拉伯
  • 南非
  • 丹麦
  • 荷兰
  • 卡达
  • 芬兰
  • 瑞典
  • 奈及利亚
  • 埃及
  • 土耳其
  • 以色列
  • 挪威
  • 波兰
  • 瑞士

15. 亚太地区吸入麻醉剂市场

  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • 印尼
  • 泰国
  • 菲律宾
  • 马来西亚
  • 新加坡
  • 越南
  • 台湾

第十六章竞争格局

  • 2024年市占率分析
  • 2024年FPNV定位矩阵
  • 竞争分析
    • Baxter International Inc.
    • Halocarbon Life Sciences
    • Lunan Pharmaceutical Group Co. Ltd.
    • AbbVie Inc.
    • Piramal Enterprises Limited
    • Fresenius Kabi AG
    • Hikma Pharmaceuticals PLC
    • Troikaa Pharmaceuticals Ltd.
    • Maruishi Pharmaceutical Co., Ltd.
    • Pfizer Inc.
    • Jiangsu Hengrui Medicine Co., Ltd.
    • Yichang Humanwell Pharmaceutical Co., Ltd.
    • Zoetis Inc.
    • Draegerwerk AG & Co. KGaA
    • Linde PLC
    • Dechra Pharmaceuticals PLC
    • Halocarbon Products Corporation
    • RAMAN WEIL
    • Piramal Critical Care Limited
    • Aetos Pharma Private Limited
    • NextSource Pharma
    • Dechra Veterinary Products

第十七章 研究人工智慧

第十八章 研究统计

第十九章 研究联络人

第二十章 研究报导

第21章 附录

Product Code: MRR-742BD517FC4B

The Inhalation Anesthetics Market was valued at USD 1.62 billion in 2024 and is projected to grow to USD 1.75 billion in 2025, with a CAGR of 8.41%, reaching USD 2.63 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 1.62 billion
Estimated Year [2025] USD 1.75 billion
Forecast Year [2030] USD 2.63 billion
CAGR (%) 8.41%

Exploring the Transformative Role and Advancements in Inhalation Anesthetics That Are Redefining Safety Efficiency and Outcomes Across Contemporary Surgical and Critical Care Settings

Inhalation anesthetics have been a cornerstone of modern anesthesia practice for nearly two centuries, evolving from rudimentary ether and chloroform formulations to sophisticated agents designed for rapid onset, precise control, and minimal side effects. This introduction charts the technological breakthroughs that have transformed surgical care, enabling clinicians to deliver consistent, safe anesthesia in a wide range of operative settings. By harnessing volatile and gaseous anesthetic compounds, practitioners can tailor sedation depth and recovery profiles to individual patient needs.

A growing emphasis on patient safety and operational efficiency has spurred continuous innovation in drug design, delivery systems, and monitoring technologies. Anesthesiologists now benefit from advanced vaporizer devices, automated anesthesia workstations, and real-time respiratory analytics that collectively enhance precision and reduce perioperative risks. As global healthcare systems face rising demand for surgical interventions, the availability and reliability of inhalation anesthetics play a critical role in sustaining high-quality outcomes.

In this context, stakeholders across the supply chain-ranging from chemical manufacturers to hospital procurement teams-must navigate a complex interplay of regulatory requirements, environmental considerations, and cost pressures. Understanding the foundational science, product classifications, and clinical applications of inhalation anesthetics is essential for informed decision making. This executive summary lays out the essential landscape, spotlighting transformative shifts, regulatory impacts, segmentation insights, and regional patterns that define the current state and future trajectory of inhalation anesthesia.

Assessing the Pivotal Shifts in Technology Administration and Regulatory Frameworks That Are Driving a New Era of Efficiency Safety and Precision in Inhalation Anesthesia

The inhalation anesthetics landscape is undergoing rapid evolution driven by technological innovation, heightened safety standards, and environmental sustainability mandates. Recent years have seen the integration of closed-circuit anesthesia delivery systems that minimize waste gas emissions and optimize agent utilization. These systems, when paired with sophisticated monitoring tools, provide clinicians with granular control over anesthetic concentration, ventilation parameters, and patient hemodynamics, reducing the risk of intraoperative instability.

Regulatory agencies have responded to environmental concerns by updating guidelines on greenhouse gas emissions and occupational exposure limits, compelling manufacturers to refine agent formulations and delivery mechanisms. Concurrently, digital health platforms are enabling remote monitoring and analytics, creating opportunities for decentralized anesthesia clinics and tele-anesthesia services. Artificial intelligence algorithms are beginning to assist with predictive dosing models, further personalizing anesthesia plans and improving patient throughput.

These shifts not only enhance clinical outcomes but also reshape competitive dynamics, as companies invest heavily in R&D collaborations, strategic alliances, and intellectual property portfolios. The convergence of precision medicine principles with advanced anesthetic technologies heralds a new era of customized perioperative care, where safety, sustainability, and efficiency are paramount. As the industry navigates these transformative shifts, stakeholders must align innovation pipelines with emerging regulatory frameworks and evolving provider needs.

Analyzing the Comprehensive Effects of the 2025 United States Tariffs on Supply Chains Operational Costs and Strategic Sourcing Decisions Impacting Inhalation Anesthetic Providers

The implementation of new United States tariffs in 2025 has introduced multifaceted challenges across the inhalation anesthetics supply chain, affecting raw material procurement, manufacturing costs, and distribution economics. Suppliers reliant on imported precursor chemicals have experienced elevated input expenses, prompting strategic reassessments of sourcing channels and contract terms. In turn, manufacturers are reviewing their production footprints and evaluating nearshoring or domestic expansion to mitigate tariff burdens.

These cost pressures have implications for healthcare providers as well, who must balance budget constraints with the imperative to maintain access to high-quality anesthetic agents. Some institutions are exploring collaborative purchasing agreements and alternative formulations to manage expenditures without compromising patient care. Others are implementing inventory management platforms to optimize order quantities and reduce stock-out risks amid price volatility.

Over time, the cumulative tariff impact may accelerate diversification of global supply networks, encouraging partnerships with non-US suppliers or investment in emerging markets with favorable trade arrangements. Industry participants are also advocating for policy adjustments through trade associations, seeking clarity on tariff classifications and exploring exemptions for clinical applications. As the landscape stabilizes, the ability to adapt swiftly to regulatory cost shifts will distinguish resilient players and shape the long-term availability and affordability of inhalation anesthetic agents.

Decrypting Key Segmentation Dynamics to Understand How Product Types Age Groups Applications End Users and Distribution Channels Are Shaping Diverse Inhalation Anesthetic Market Niches

Understanding the diverse pathways through which inhalation anesthetic products serve clinical needs requires a close examination of market segmentation. The distinction between gaseous anesthetics and volatile anesthetics highlights fundamental differences in formulation and delivery, with the latter category encompassing agents such as Desflurane, Enflurane, Halothane, Isoflurane, and Sevoflurane, each offering unique pharmacokinetic profiles and recovery characteristics. These product-level nuances affect clinician preferences and purchasing decisions, especially when balancing onset speed against metabolic burden.

Age-based segmentation further reveals varying demand patterns, as adult patients often require higher throughput solutions, while geriatric populations benefit from agents with minimal hemodynamic impact and rapid recovery. Pediatric anesthesia, in contrast, demands formulations that allow for precise titration to ensure both safety and comfort during induction and emergence. The interplay between patient demographics and agent selection drives tailored inventory strategies within healthcare facilities.

Applications in induction of anesthesia versus maintenance of anesthesia underscore the operational divides in clinical workflows. Agents favored for rapid induction may differ from those optimized for prolonged surgical procedures, influencing the composition of anesthesia carts and pipeline setups in operating theaters. End users such as ambulatory surgical centers, hospitals, intensive care units, military or field hospitals, specialty clinics, and veterinary clinics each present distinct usage profiles, requiring suppliers to adapt packaging sizes, delivery devices, and training support accordingly.

Finally, distribution channels ranging from traditional offline medical distributors to emerging online platforms shape accessibility and purchasing convenience. While established healthcare systems may rely on long-standing contracts with brick-and-mortar suppliers, smaller clinics and veterinary practices are increasingly leveraging digital marketplaces for rapid order fulfillment and competitive pricing. This dual-channel environment necessitates flexible supply strategies to capture opportunities across all buyer segments.

Mapping Regional Growth Trajectories to Reveal How the Americas Europe Middle East and Africa and Asia Pacific Regions Are Influencing Demand and Strategic Focus in Inhalation Anesthesia

Regional dynamics play a pivotal role in shaping market opportunities and challenges for inhalation anesthetic stakeholders. In the Americas, advanced healthcare infrastructure and extensive surgical volumes drive sustained demand for premium anesthetic agents and connected delivery systems. Regulatory bodies in the United States and Canada emphasize stringent safety and environmental standards, fostering an environment where innovation in low-emission vaporizers and agent formulations is highly prized.

In Europe, the Middle East, and Africa, heterogeneity in healthcare access and reimbursement frameworks creates a spectrum of adoption rates. Western European nations lead in implementation of next-generation anesthesia platforms, while emerging economies within the region are gradually building capacity to support expanding surgical caseloads. Navigating diverse regulatory landscapes and procurement models necessitates localized strategies that address cost sensitivities and infrastructure limitations.

The Asia Pacific region exhibits one of the fastest growth trajectories, fueled by rising healthcare investments, expanding middle-class populations, and a surge in elective procedures. Markets in East Asia are characterized by rapid technology uptake and strong partnerships between global manufacturers and local distributors. In South and Southeast Asia, there is an increasing focus on capacity building through training programs and public-private collaborations to improve anesthesia safety and access.

Across all regions, the need to harmonize quality, affordability, and environmental compliance continues to drive cross-border alliances and knowledge exchange. Success in these diverse geographies hinges on the ability to tailor product offerings, service models, and regulatory engagement strategies to each region's unique healthcare ecosystem.

Illuminating Strategic Moves and Competitive Positioning of Leading Players to Highlight Innovations Collaborations and Market Approaches Shaping the Inhalation Anesthetics Industry Landscape

Leading companies in the inhalation anesthetics space are deploying a range of strategies to maintain competitive advantage and capture emerging opportunities. Many have accelerated investments in green chemistry and closed-loop delivery technologies to meet evolving environmental regulations and end user demands. Strategic collaborations with medical device firms and software developers are enabling integrated anesthesia platforms that combine agent delivery with advanced analytics for enhanced patient monitoring.

Some key players are expanding their geographic reach through acquisitions of regional distributors, establishing local manufacturing partnerships to reduce lead times and tariff exposures. Others are prioritizing research into novel anesthetic compounds with optimized safety profiles, targeting specific patient populations such as pediatrics or those with complex comorbidities. Robust clinical trial pipelines and real-world evidence studies underpin these innovation efforts, reinforcing brand credibility among healthcare practitioners.

To enhance customer engagement, leading suppliers offer comprehensive training programs, certification courses, and digital support tools that facilitate best practices in inhalation anesthetic administration. These value-added services not only improve clinical outcomes but also strengthen long-term relationships with high-volume accounts such as hospitals and ambulatory surgical centers. By aligning product development, regulatory strategy, and customer support, top companies continue to shape the future direction of the inhalation anesthetics industry.

Delivering Actionable Strategic Recommendations to Empower Industry Leaders in Navigating Regulatory Complexities Innovation Imperatives and Market Entry Challenges in the Inhalation Anesthetic Domain

Industry leaders can strengthen their market position by pursuing several actionable strategies. First, prioritizing research and development in low-emission anesthetic agents and closed-circuit delivery systems will differentiate offerings amid tightening environmental regulations. Investing in formulation science and device integration will help address both clinician preferences and sustainability imperatives.

Second, diversifying supply chains through nearshoring partnerships or multi-source agreements can mitigate the risks associated with tariff fluctuations and raw material shortages. Proactive engagement with trade associations and policy makers will also enable companies to shape regulatory outcomes and secure favorable treatment for critical clinical products.

Third, expanding digital capabilities by incorporating predictive analytics, remote monitoring, and e-commerce platforms will enhance customer accessibility and operational efficiency. Tailored training programs and tele-anesthesia services can improve adoption rates in emerging markets and specialized care settings.

Finally, forging strategic alliances with healthcare providers, academic institutions, and technology firms will accelerate innovation cycles and create integrated solutions that span drug delivery, monitoring, and outcome optimization. By leveraging collaborative ecosystems and embracing agile development methodologies, industry leaders will be better positioned to navigate evolving clinical needs and competitive pressures.

Elucidating the Rigorous Research Methodology That Underpins Reliable Data Collection Analysis Validation and Insights in the Study of Inhalation Anesthetics Market Dynamics

The research underpinning this analysis employed a comprehensive, multi-tiered methodology designed to ensure accuracy, reliability, and relevance. Primary research comprised in-depth interviews with key opinion leaders, including anesthesiologists, procurement managers, regulatory experts, and device engineers. These firsthand insights provided nuanced understanding of clinical preferences, operational challenges, and technology adoption barriers.

Secondary research involved a systematic review of scientific literature, patent filings, regulatory filings, and industry publications to map historical trends and emerging breakthroughs. Data sources were meticulously vetted with an emphasis on peer-reviewed journals, health authority databases, and credible industry reports. Quantitative data was triangulated across multiple reference points to validate consistency and identify discrepancies.

Analytical frameworks such as PEST analysis, SWOT evaluation, and segmentation matrices were applied to distill key market drivers, risks, and growth opportunities. Geographic and application-specific analyses provided deeper granularity, while scenario planning exercises modeled the potential impacts of regulatory changes, tariff implementations, and technology disruptions.

Quality control protocols included peer reviews by domain experts and quantitative checks to ensure data integrity. The resulting insights offer a well-rounded perspective on inhalation anesthetics, supporting informed decision making for stakeholders seeking actionable intelligence and strategic clarity.

Concluding Insights That Synthesize Critical Trends Technological Advancements Regulatory Impacts and Competitive Strategies Defining the Future Trajectory of the Inhalation Anesthetics Sector

The inhalation anesthetics sector stands at the intersection of clinical innovation, regulatory evolution, and sustainability imperatives. Technological advancements in agent formulations and delivery systems are enhancing safety, operational efficiency, and environmental performance. At the same time, regulatory shifts-exemplified by new tariff regimes and emission guidelines-are reshaping supply chain strategies and cost structures.

Segmentation analysis underscores the importance of product type differentiation, patient age cohorts, clinical applications, end user settings, and distribution channels, each of which influences demand patterns and competitive positioning. Regional insights reveal distinct trajectories in the Americas, Europe, Middle East & Africa, and Asia Pacific, highlighting the need for adaptive strategies tailored to local healthcare infrastructures and policy environments.

Leading companies are responding with innovation pipelines, strategic collaborations, and customer-centric services that bolster clinical outcomes and foster long-term partnerships. Actionable recommendations emphasize the value of sustainable R&D investments, supply chain diversification, digital transformation, and alliance building to navigate complexity and capitalize on emerging opportunities.

By integrating these multidimensional insights, stakeholders can chart a clear path forward, ensuring that inhalation anesthetics continue to advance patient care, operational excellence, and environmental stewardship. The culmination of this analysis provides a robust foundation for strategic planning and competitive differentiation in a rapidly evolving market landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Market Sizing & Forecasting

5. Market Dynamics

  • 5.1. Rising adoption of low-impact anesthetic agents to reduce OR carbon footprint
  • 5.2. Increased regulatory approvals for next-generation desflurane alternatives with lower emissions
  • 5.3. Growing demand for ultra-fast onset inhalation anesthetics in ambulatory surgery centers
  • 5.4. Expansion of inhalation anesthetic markets across Asia-Pacific emerging healthcare systems
  • 5.5. Shift towards eco-friendly anesthetic protocols in response to global sustainability mandates
  • 5.6. Competitive pricing pressures from generic inhalation anesthetic substitutes in developed markets

6. Market Insights

  • 6.1. Porter's Five Forces Analysis
  • 6.2. PESTLE Analysis

7. Cumulative Impact of United States Tariffs 2025

8. Inhalation Anesthetics Market, by Product Type

  • 8.1. Introduction
  • 8.2. Gaseous Anesthetics
  • 8.3. Volatile Anesthetics
    • 8.3.1. Desflurane
    • 8.3.2. Enflurane
    • 8.3.3. Halothane
    • 8.3.4. Isoflurane
    • 8.3.5. Sevoflurane

9. Inhalation Anesthetics Market, by Age Group

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Geriatric
  • 9.4. Pediatric

10. Inhalation Anesthetics Market, by Application

  • 10.1. Introduction
  • 10.2. Induction of Anesthesia
  • 10.3. Maintenance of Anesthesia

11. Inhalation Anesthetics Market, by End User

  • 11.1. Introduction
  • 11.2. Ambulatory Surgical Centers (ASCs)
  • 11.3. Hospitals
  • 11.4. ICUs
  • 11.5. Military/Field Hospitals
  • 11.6. Specialty Clinics
  • 11.7. Veterinary Clinics

12. Inhalation Anesthetics Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Offline
  • 12.3. Online

13. Americas Inhalation Anesthetics Market

  • 13.1. Introduction
  • 13.2. United States
  • 13.3. Canada
  • 13.4. Mexico
  • 13.5. Brazil
  • 13.6. Argentina

14. Europe, Middle East & Africa Inhalation Anesthetics Market

  • 14.1. Introduction
  • 14.2. United Kingdom
  • 14.3. Germany
  • 14.4. France
  • 14.5. Russia
  • 14.6. Italy
  • 14.7. Spain
  • 14.8. United Arab Emirates
  • 14.9. Saudi Arabia
  • 14.10. South Africa
  • 14.11. Denmark
  • 14.12. Netherlands
  • 14.13. Qatar
  • 14.14. Finland
  • 14.15. Sweden
  • 14.16. Nigeria
  • 14.17. Egypt
  • 14.18. Turkey
  • 14.19. Israel
  • 14.20. Norway
  • 14.21. Poland
  • 14.22. Switzerland

15. Asia-Pacific Inhalation Anesthetics Market

  • 15.1. Introduction
  • 15.2. China
  • 15.3. India
  • 15.4. Japan
  • 15.5. Australia
  • 15.6. South Korea
  • 15.7. Indonesia
  • 15.8. Thailand
  • 15.9. Philippines
  • 15.10. Malaysia
  • 15.11. Singapore
  • 15.12. Vietnam
  • 15.13. Taiwan

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Baxter International Inc.
    • 16.3.2. Halocarbon Life Sciences
    • 16.3.3. Lunan Pharmaceutical Group Co. Ltd.
    • 16.3.4. AbbVie Inc.
    • 16.3.5. Piramal Enterprises Limited
    • 16.3.6. Fresenius Kabi AG
    • 16.3.7. Hikma Pharmaceuticals PLC
    • 16.3.8. Troikaa Pharmaceuticals Ltd.
    • 16.3.9. Maruishi Pharmaceutical Co., Ltd.
    • 16.3.10. Pfizer Inc.
    • 16.3.11. Jiangsu Hengrui Medicine Co., Ltd.
    • 16.3.12. Yichang Humanwell Pharmaceutical Co., Ltd.
    • 16.3.13. Zoetis Inc.
    • 16.3.14. Draegerwerk AG & Co. KGaA
    • 16.3.15. Linde PLC
    • 16.3.16. Dechra Pharmaceuticals PLC
    • 16.3.17. Halocarbon Products Corporation
    • 16.3.18. RAMAN WEIL
    • 16.3.19. Piramal Critical Care Limited
    • 16.3.20. Aetos Pharma Private Limited
    • 16.3.21. NextSource Pharma
    • 16.3.22. Dechra Veterinary Products

17. ResearchAI

18. ResearchStatistics

19. ResearchContacts

20. ResearchArticles

21. Appendix

LIST OF FIGURES

  • FIGURE 1. INHALATION ANESTHETICS MARKET RESEARCH PROCESS
  • FIGURE 2. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2024 VS 2030 (%)
  • FIGURE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2024 VS 2030 (%)
  • FIGURE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 16. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 18. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 21. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 22. ASIA-PACIFIC INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 23. INHALATION ANESTHETICS MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 24. INHALATION ANESTHETICS MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 25. INHALATION ANESTHETICS MARKET: RESEARCHAI
  • FIGURE 26. INHALATION ANESTHETICS MARKET: RESEARCHSTATISTICS
  • FIGURE 27. INHALATION ANESTHETICS MARKET: RESEARCHCONTACTS
  • FIGURE 28. INHALATION ANESTHETICS MARKET: RESEARCHARTICLES

LIST OF TABLES

  • TABLE 1. INHALATION ANESTHETICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL INHALATION ANESTHETICS MARKET SIZE, 2025-2030 (USD MILLION)
  • TABLE 5. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 7. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 9. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 11. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GASEOUS ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GASEOUS ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 13. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 15. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DESFLURANE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 17. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ENFLURANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ENFLURANE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 19. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HALOTHANE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 21. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ISOFLURANE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 23. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SEVOFLURANE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 25. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 27. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 29. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ADULT, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 31. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GERIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY GERIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 33. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 35. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 37. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY INDUCTION OF ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY INDUCTION OF ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 39. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MAINTENANCE OF ANESTHESIA, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MAINTENANCE OF ANESTHESIA, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 41. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 43. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS (ASCS), BY REGION, 2025-2030 (USD MILLION)
  • TABLE 45. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 47. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ICUS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ICUS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 49. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MILITARY/FIELD HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY MILITARY/FIELD HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 51. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 53. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY VETERINARY CLINICS, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 55. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 57. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY OFFLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 59. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ONLINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL INHALATION ANESTHETICS MARKET SIZE, BY ONLINE, BY REGION, 2025-2030 (USD MILLION)
  • TABLE 61. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 62. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 63. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 64. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 65. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 66. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 67. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 68. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 69. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 70. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 71. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 72. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 73. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 74. AMERICAS INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 75. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 76. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 77. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 78. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 79. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 80. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 81. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 82. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 83. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 84. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 85. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 86. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 87. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
  • TABLE 88. UNITED STATES INHALATION ANESTHETICS MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
  • TABLE 89. CANADA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 90. CANADA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 91. CANADA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 92. CANADA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 93. CANADA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. CANADA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 95. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 96. CANADA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 97. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 98. CANADA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 99. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 100. CANADA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 101. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 102. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 103. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 104. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 105. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 106. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 107. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 108. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 109. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 110. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 111. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 112. MEXICO INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 113. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 114. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 115. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 116. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 117. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 118. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 119. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 120. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 121. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 122. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 123. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 124. BRAZIL INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 125. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 126. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 127. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 128. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 129. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 130. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 131. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 132. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 133. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 134. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 135. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 136. ARGENTINA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 139. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 140. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 141. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 143. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 144. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA INHALATION ANESTHETICS MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
  • TABLE 151. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 152. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 153. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 154. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 155. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 156. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 157. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 158. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 159. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 160. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 161. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 162. UNITED KINGDOM INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 163. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 164. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 165. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 166. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 167. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 168. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 169. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 170. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 171. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 172. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 173. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 174. GERMANY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 175. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 177. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 178. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 179. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 181. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 182. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 183. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 184. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 185. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 186. FRANCE INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 187. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 188. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 189. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 190. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 191. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 193. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 194. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 195. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 196. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 197. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 198. RUSSIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 199. ITALY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 200. ITALY INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 201. ITALY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 202. ITALY INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 203. ITALY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 204. ITALY INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 205. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 206. ITALY INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 207. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 208. ITALY INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 209. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 210. ITALY INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 211. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 212. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 213. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 214. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 215. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 216. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 217. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 218. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 219. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 220. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 221. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 222. SPAIN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 223. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 224. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 235. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 236. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 237. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 238. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 239. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 240. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 242. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 248. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 254. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 255. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 256. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 257. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 258. SOUTH AFRICA INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 259. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 260. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 261. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 262. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 263. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 264. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 265. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 266. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 267. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 268. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 269. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 270. DENMARK INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 271. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 273. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 274. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 275. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 276. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 277. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 278. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 279. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 280. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 281. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 282. NETHERLANDS INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 283. QATAR INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 284. QATAR INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 285. QATAR INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 286. QATAR INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 287. QATAR INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 288. QATAR INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 289. QATAR INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 290. QATAR INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 291. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 292. QATAR INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 293. QATAR INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 294. QATAR INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 295. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 296. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 297. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 298. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 299. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 300. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 301. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 302. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 303. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 304. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 305. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 306. FINLAND INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 307. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 308. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 309. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 310. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 311. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 312. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 313. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 314. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 315. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 316. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 317. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
  • TABLE 318. SWEDEN INHALATION ANESTHETICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
  • TABLE 319. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 320. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
  • TABLE 321. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2018-2024 (USD MILLION)
  • TABLE 322. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY VOLATILE ANESTHETICS, 2025-2030 (USD MILLION)
  • TABLE 323. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2018-2024 (USD MILLION)
  • TABLE 324. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY AGE GROUP, 2025-2030 (USD MILLION)
  • TABLE 325. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 326. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY APPLICATION, 2025-2030 (USD MILLION)
  • TABLE 327. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 328. NIGERIA INHALATION ANESTHETICS MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
  • TABLE 329. NIGERIA INHALATION ANESTHETICS MARKET SIZE,